Latka logo
Nyxoah logo

Nyxoahrevenue & market cap

Mont-Saint-Guibert, BelgiumFounded 2009

Public company

Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA).

nyxoah.comLinkedInUpdated Sep 28, 2026
Annual revenue
$11.4M
Dec 2025 · Stock Analysis
Market cap
$160.4M
Sep 2026

Nyxoah revenue

Nyxoah's annual revenue was $11.4M in December 2025 (Stock Analysis; converted from euros).

$0
$5M
$10M
$0
–
$5.1M
$11.4M
20092010–2320242025
ReportedFounded 2009 at $0; every reading has its own bar
All 2 revenue readings, with sources
As ofRevenueSource
Dec 2024$5.1MStock Analysisconverted from euros
Dec 2025$11.4MStock Analysisconverted from euros

Nyxoah market cap

Nyxoah is a public company. Its market capitalisation was $160.4M in September 2026.

Nyxoah FAQ

What is Nyxoah's revenue?

Nyxoah's annual revenue was $11.4M in December 2025, according to Stock Analysis.

Is Nyxoah publicly traded?

Yes. Nyxoah is a public company, with a market capitalisation of $160.4M in September 2026.

Categories

How this page is sourced

2 from public sources. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Sep 28, 2026Data disclaimerReport a correctionClaim this profileRun Nyxoah? Join the podcast